11 patents
Utility
Methods and Compositions for Treating Diabetes
6 Jul 23
Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
MIRIAM KIDRON
Filed: 29 Jun 22
Utility
Methods and Compositions for Oral Administration of Proteins
26 May 22
This invention provides compositions comprising a protein and an omega-3 fatty acid, method for treating diabetes mellitus, comprising administering same, and methods for oral administration of a protein with an enzymatic activity, comprising orally administering same.
Miriam Kidron
Filed: 29 Nov 21
Utility
Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
6 Jan 22
Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of nonalcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
Miriam KIDRON, Ehud ARBIT
Filed: 19 Mar 21
Utility
Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same
2 Dec 21
Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
Avraham HERSHKO, Miriam KIDRON
Filed: 1 Feb 21
Utility
Methods and Compositions for Oral Administration of Exenatide
21 Oct 21
This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.
Miriam Kidron
Filed: 29 Apr 21
Utility
Recombinant Protease Inhibitor-Containing Compositions, Methods for Producing Same and Uses Thereof
12 Aug 21
Provided herein are compositions for oral administration of therapeutic proteins and peptides, which compositions contain an isolated recombinantly expressed Bowman-Birk inhibitor (BBI) and which compositions provide for improved sustained activity of the therapeutic proteins and peptides.
Miriam Kidron, Kajal Arora, Ramachandra Nagaraju, Nupur Mehrotra Arora, Prabuddha Kundu
Filed: 6 Jun 19
Utility
Methods and Compositions for Oral Administration of Proteins
22 Apr 21
This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
Miriam KIDRON
Filed: 23 Dec 20
Utility
Methods and Compositions for Treating Diabetes
18 Mar 21
Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
Miriam Kidron
Filed: 23 Mar 20
Utility
Methods and Compositions for Treating Diabetes
11 Dec 19
Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
Miriam Kidron
Filed: 26 Aug 19
Utility
Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same
23 Oct 19
Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
Avraham Hershko, Miriam Kidron
Filed: 8 May 19
Utility
Methods and Compositions for Rectal Administration of Exenatide
16 Oct 19
This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.
Miriam Kidron
Filed: 9 Jun 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first